Could a simple additive make C-Section anesthesia safer and faster?

NCT ID NCT07465185

Recruiting now Symptom relief Sponsor: Benha University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests whether adding dexmedetomidine to the standard spinal anesthetic bupivacaine improves pain relief and recovery for women undergoing planned C-sections. 300 full-term pregnant women will be randomly assigned to receive either bupivacaine alone or bupivacaine plus dexmedetomidine. The goal is to see if the combination provides faster onset and shorter duration of numbness, leading to better recovery quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine and dexmedetomidine
What this could lead to: If successful, this could lead to a safer, more effective spinal anesthesia option for C-sections, with quicker recovery and fewer side effects.
What could go wrong: This is an early phase 2 trial with 300 participants, so results may not apply to all patients. Adding dexmedetomidine could also cause unexpected side effects like low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA

Contacts and locations

Locations

Banha Faculity of Medicine
RECRUITING

Banhā, Elqalyoubea,, 13511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.